We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-8.76%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.31% |
| 2 | Technology | 17.95% |
| 3 | Communication Services | 13.61% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Belden
BDC
$5.19B
| $226K | ﹤0.01% |
+4,447
| New | +$217K |
|
1327
Adaptive Biotechnologies
ADPT
$3.97B
| $225K | ﹤0.01% |
5,498
-26,698
| -83% | -$1.04M |
|
1328
Arrowhead Research
ARWR
$12.4B
| $224K | ﹤0.01% |
+2,710
| New | +$202K |
|
|
NS
1329
DELISTED
NuStar Energy L.P.
NS
| $224K | ﹤0.01% |
+12,416
| New | +$230K |
|
|
EXAS
1330
DELISTED
Exact Sciences
EXAS
| $223K | ﹤0.01% |
1,792
-19,646
| -92% | -$2.34M |
|
|
DSPG
1331
DELISTED
DSP Group Inc
DSPG
| $223K | ﹤0.01% |
+15,066
| New | +$225K |
|
1332
Repligen
RGEN
$9.25B
| $219K | ﹤0.01% |
1,095
-150,149
| -99% | -$29.1M |
|
|
FFWM
1333
DELISTED
First Foundation Inc
FFWM
| $217K | ﹤0.01% |
9,621
-9,821
| -51% | -$236K |
|
1334
Outdoor Holding Co
POWW
$247M
| $217K | ﹤0.01% |
+22,185
| New | +$158K |
|
|
CIXX
1335
DELISTED
CI Financial Corp.
CIXX
| $217K | ﹤0.01% |
11,800
-823,366
| -99% | -$14.1M |
|
1336
CareDx
CDNA
$2.42B
| $215K | ﹤0.01% |
2,344
-30,255
| -93% | -$2.4M |
|
1337
AMN Healthcare
AMN
$1.4B
| $210K | ﹤0.01% |
2,166
-5,118
| -70% | -$444K |
|
1338
AZZ Inc
AZZ
$4.54B
| $210K | ﹤0.01% |
+4,064
| New | +$214K |
|
1339
Investar Holding Corp
ISTR
$414M
| $210K | ﹤0.01% |
+9,156
| New | +$202K |
|
|
PAYA
1340
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $210K | ﹤0.01% |
19,090
-908,571
| -98% | -$9.68M |
|
|
SEGG
1341
Sports Entertainment Gaming Global Corp
SEGG
$8.25M
| $209K | ﹤0.01% |
12
-46
| -79% | -$796K |
|
1342
Cloudflare
NET
$107B
| $209K | ﹤0.01% |
+1,974
| New | +$163K |
|
|
BLDP
1343
Ballard Power Systems
BLDP
$790M
| $208K | ﹤0.01% |
+11,493
| New | +$214K |
|
1344
LG Display
LPL
$3.3B
| $208K | ﹤0.01% |
+19,562
| New | +$209K |
|
|
SAND
1345
DELISTED
Sandstorm Gold
SAND
| $208K | ﹤0.01% |
+26,300
| New | +$213K |
|
1346
GE Aerospace
GE
$384B
| $206K | ﹤0.01% |
3,071
-346,539
| -99% | -$23.1M |
|
|
EAR
1347
DELISTED
Eargo, Inc. Common Stock
EAR
| $206K | ﹤0.01% |
257
-518
| -67% | -$434K |
|
1348
Banco Santander Chile
BSAC
$16.6B
| $205K | ﹤0.01% |
10,338
-1,476
| -12% | -$33K |
|
1349
Extreme Networks
EXTR
$3.15B
| $202K | ﹤0.01% |
+18,084
| New | +$192K |
|
|
EMKR
1350
DELISTED
Emcore Corp
EMKR
| $200K | ﹤0.01% |
+2,171
| New | +$175K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.